Literature DB >> 10878571

The structure and function of HFE.

H Drakesmith1, A Townsend.   

Abstract

The iron overload disease hereditary haemochromatosis (HH) occurs in about 1 in 300 Caucasians; the protein mutated in this disorder is termed HFE.(1) HFE is homologous to major histocompatibility complex (MHC) class I proteins, but unlike MHC class I molecules, HFE does not present peptides to T cells.(2) The transferrin receptor (TfR) is a ligand for HFE, and the crystal structure of the HFE-TfR complex has been determined.(3) The many interesting features of this structure illustrate the diverse roles of the MHC fold in nature and clarify how HFE affects TfR function. Whether the interaction between HFE and TfR explains the pathogenesis of HH is not so clear.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878571     DOI: 10.1002/1521-1878(200007)22:7<595::AID-BIES1>3.0.CO;2-E

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  6 in total

1.  Sequence variation and haplotype structure at the human HFE locus.

Authors:  Christopher Toomajian; Martin Kreitman
Journal:  Genetics       Date:  2002-08       Impact factor: 4.562

2.  The hemochromatosis protein HFE inhibits iron export from macrophages.

Authors:  Hal Drakesmith; Emma Sweetland; Lisa Schimanski; Jon Edwards; Diana Cowley; Mubeen Ashraf; Judy Bastin; Alain R M Townsend
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

Review 3.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  A quantitative trait locus on chromosome 4 affects cycling of hematopoietic stem and progenitor cells through regulation of TGF-beta 2 responsiveness.

Authors:  Serine Avagyan; Ludmila Glouchkova; Juhyun Choi; Hans-Willem Snoeck
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

5.  Regulation of HFE expression by poly(ADP-ribose) polymerase-1 (PARP1) through an inverted repeat DNA sequence in the distal promoter.

Authors:  Christopher Pelham; Tamara Jimenez; Marianna Rodova; Angela Rudolph; Elizabeth Chipps; M Rafiq Islam
Journal:  Biochim Biophys Acta       Date:  2013-10-29

Review 6.  Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

Authors:  Anne Halenius; Carolin Gerke; Hartmut Hengel
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.